2025-01-01 2025-12-31 false true CMF S.r.l 42/A via Cuorgne, Rivoli, Torino, 10098 Italy Capium Accounts Production 1.1 03561938 2025-01-01 2025-12-31 03561938 bus:AbridgedAccounts 2025-01-01 2025-12-31 03561938 bus:FRS102 2025-01-01 2025-12-31 03561938 bus:Audited 2025-01-01 2025-12-31 03561938 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 03561938 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 03561938 2025-01-01 2025-12-31 03561938 2025-12-31 03561938 bus:RegisteredOffice 2025-01-01 2025-12-31 03561938 core:WithinOneYear 2025-12-31 03561938 core:AfterOneYear 2025-12-31 03561938 1 2025-01-01 2025-12-31 03561938 bus:Director1 2025-01-01 2025-12-31 03561938 bus:Director1 2025-12-31 03561938 bus:Director1 2024-01-01 2024-12-31 03561938 bus:Director2 2025-01-01 2025-12-31 03561938 bus:Director2 2025-12-31 03561938 bus:Director2 2024-01-01 2024-12-31 03561938 2024-01-01 03561938 bus:LeadAgentIfApplicable 2025-01-01 2025-12-31 03561938 2024-01-01 2024-12-31 03561938 2024-12-31 03561938 core:WithinOneYear 2024-12-31 03561938 core:AfterOneYear 2024-12-31 03561938 bus:EntityAccountantsOrAuditors 2024-01-01 2024-12-31 03561938 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 03561938 bus:OrdinaryShareClass1 2025-12-31 03561938 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 03561938 bus:OrdinaryShareClass1 2024-12-31 03561938 core:LandBuildings 2025-01-01 2025-12-31 03561938 core:LandBuildings 2025-12-31 03561938 core:LandBuildings 2024-12-31 03561938 core:PlantMachinery 2025-01-01 2025-12-31 03561938 core:PlantMachinery 2025-12-31 03561938 core:PlantMachinery 2024-12-31 03561938 core:FurnitureFittings 2025-01-01 2025-12-31 03561938 core:FurnitureFittings 2025-12-31 03561938 core:FurnitureFittings 2024-12-31 03561938 core:ComputerEquipment 2025-01-01 2025-12-31 03561938 core:ComputerEquipment 2025-12-31 03561938 core:ComputerEquipment 2024-12-31 03561938 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-12-31 03561938 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 03561938 core:CostValuation core:Non-currentFinancialInstruments 2025-12-31 03561938 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 03561938 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-12-31 03561938 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 03561938 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 03561938 core:Non-currentFinancialInstruments 2025-12-31 03561938 core:Non-currentFinancialInstruments 2024-12-31 03561938 core:ShareCapital 2025-12-31 03561938 core:ShareCapital 2024-12-31 03561938 core:RetainedEarningsAccumulatedLosses 2025-12-31 03561938 core:RetainedEarningsAccumulatedLosses 2024-12-31 03561938 dpl:Item1 2025-01-01 03561938 dpl:Item1 2025-12-31 03561938 dpl:Item1 2024-01-01 03561938 dpl:Item1 2024-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 03561938
England and Wales

 

 

 


Abridged Financial Statements


for the year ended 31 December 2025

for

APPLIED MEDICAL TECHNOLOGY LIMITED

 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 4 28,556    18,548 
28,556    18,548 
Current assets      
Stocks 153,130    382,932 
Debtors 159,504    137,321 
Cash at bank and in hand 821,043    881,819 
1,133,677    1,402,072 
Creditors: amount falling due within one year (240,706)   (243,454)
Net current assets 892,971    1,158,618 
 
Total assets less current liabilities 921,527    1,177,166 
Provisions for liabilities 1,992    (1,094)
Net assets 923,519    1,176,072 
 

Capital and reserves
     
Called up share capital 5 20    20 
Profit and loss account 923,499    1,176,052 
Shareholders' funds 923,519    1,176,072 
 


These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the profit and loss account has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 08 June 2026 and were signed on its behalf by:


-------------------------------
Paolo Cane
Director
1
General Information
Applied Medical Technology Limited is a private company, limited by shares, registered in England and Wales, registration number 03561938, registration address 21 Vision Business Park, Preston Place, Upper Caldecote, Biggleswade, SG18 9GQ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Going concern basis
At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods adjusted for estimated customer returns.

Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the balance sheet date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the profit and loss account.
Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.                                                                                                                                                                   
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.                                                                                                                                                                                 
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.                                                                                                                                                                                                                                                       
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.                                                                                                                                                           
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Dividends
Proposed dividends are only included as liabilities in the balance sheet when their payment has been approved by the shareholders prior to the balance sheet date.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Leasehold 5 Years Straight Line
Plant and Machinery 25% Reducing Balance
Fixtures, Fittings & Furniture 25% Reducing Balance
Computer Equipment 25% Reducing Balance
Leasing and Hire Purchase Contracts
Assets obtained under finance leases are capitalised as tangible fixed assets. Assets acquired under finance leases are depreciated over the shorter of the lease term and their useful lives. Assets acquired under hire purchase contracts are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in the creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.                                                                                                                                   
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to profit and loss account as incurred.
Stocks
Stock is valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
2.

Average number of employees

Average number of employees during the year was 3 (2024 : 2).
3.

Audit Information


The auditor's report on the accounts of Applied Medical Technology Limited for the year ended 31 December 2025 was unqualified.


The auditor's report was signed by Jaswinder S Vasir (Senior Statutory Auditor) for and on behalf of Desaur LLP, Chartered Certified Accountants Chartered Accountants and Registered Auditor on 08 June 2026.
4.

Tangible fixed assets

Cost or valuation Leasehold   Plant and Machinery   Fixtures, Fittings & Furniture   Computer Equipment   Total
  £   £   £   £   £
At 01 January 2025 5,668    6,194    10,229    30,220    52,311 
Additions 13,665    3,241    174    5,826    22,906 
Disposals     (1,441)   (7,042)   (8,483)
At 31 December 2025 19,333    9,435    8,962    29,004    66,734 
Depreciation
At 01 January 2025 1,134    3,672    8,652    20,305    33,763 
Charge for year 5,688    1,441    391    3,516    11,036 
On disposals     (1,253)   (5,368)   (6,621)
At 31 December 2025 6,822    5,113    7,790    18,453    38,178 
Net book values
Closing balance as at 31 December 2025 12,511    4,322    1,172    10,551    28,556 
Opening balance as at 01 January 2025 4,534    2,522    1,577    9,915    18,548 


5.

Share Capital

Allotted, called up and fully paid
2025
£
  2024
£
20 Ordinary shares of £1.00 each 20    20 
20    20 

6.

Other Commitments

The total of future minimum lease payments under non-cancellable operating leases are as following:
Particulars   Current
£
  Previous
£
Not later than one year 41,160  41,160 
Later than one year and not later than five years 164,640  164,640 
Later than five years 102,900  144,060 
308,700  349,860 
7.

Related parties

The Company has taken advantage of exemption, under 33.1A of the Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland", not to disclose transactions with wholly owned subsidiaries within the group.


Included in the Profit and Loss account were services received from Accountancy Professionals Ltd of £252,347 (2024 : £239,153) and Heycroft Financial Management Ltd of £92,033 (2024 : £82,135), the ex-directors companies. At the year-end, the company owed £41,467 (2024 : £24,876) to Accountancy Professionals Ltd and £25,679 (2024 : £9,803 ) to Heycroft Financial Management Ltd, which are included in creditors. 

8.

Ultimate Controlling Party

The company's immediate and ultimate parent undertaking is Cane S.p.A.

Cane S.p.A was incorporated in (Please enter country of incorporation). Copies of the group accounts may be contained from the secretary, 42/A via Cuorgne, Rivoli, Torino, 10098 Italy.

The ultimate controlling party is CMF S.r.l who controls 100% of the shares of Applied Medical Technology Limited.




2